Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC): Impact of Hepatitis B Virus (HBV) Infection
Loading...
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Open Access Color
Green Open Access
No
OpenAIRE Downloads
OpenAIRE Views
Publicly Funded
No
BIP! Indicators
Impulse
Average
Influence
Average
Popularity
Average
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1
OpenCitations Citation Count
N/A
Source
Annals of Oncology
Volume
35
Issue
Start Page
S1462
End Page
S1462
Google Scholar™
